News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
162 Results
162 Results
RECOVER study provides new insights on the relationship between pregnancy and Long COVID
Recent RECOVER findings provide insights into how changes to the immune system during pregnancy may affect a woman’s risk of developing Long COVID.
Feature
RECOVER EHR study provides additional information about pediatric Long COVID symptoms
Researchers identified six common groups of symptoms experienced by children and adolescents with Long COVID.
Feature
RECOVER researchers develop new tools to help identify Long COVID in youngest children
Researchers analyzed data from RECOVER’s pediatric observational study to better understand how Long COVID impacts infants, toddlers, and preschool-aged children.
Feature
RECOVER study identifies unique symptom patterns of Long COVID in young children
Findings from a recent RECOVER pediatric observational study show that the most common Long COVID symptoms experienced by children 0 to 5 years old can be different than those experienced by older children and adults.
News Release
R3 Seminar Recap: Understanding metformin use and Long COVID and ME/CFS following COVID-19 infection: Insights from two studies
A recent RECOVER Research Review (R3) Seminar held May 13 spotlighted research presented by Carolyn Bramante, MD, MPH (University of Minnesota) and Steve Johnson, PhD (University of Minnesota) exploring how metformin, a widely prescribed medication primarily used to manage type 2 diabetes, may help reduce the risk of Long COVID. The seminar also featured a presentation from Suzanne Vernon, PhD (Bateman Horne Center) on research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following a COVID-19 infection.
R3 Seminar Recap
Collaborating to advance Long COVID research: RECOVER researchers team up across the Pacific Northwest
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
Feature
Task force makes recommendations for studying biological systems as part of Long COVID research
Combining knowledge across different scientific specialties that study biological systems could reveal information that improves the diagnosis of Long COVID and supports the development of personalized Long COVID treatments.
Feature
RECOVER study highlights variations in Long COVID symptoms among children of different backgrounds
RECOVER researchers studied health records to understand how racial and ethnic backgrounds may impact pediatric Long COVID symptoms. These findings could support early detection and management of Long COVID symptoms for all children.
Feature